Herndon Capital Management’s AbbVie ABBV Stock Holding History

Herndon Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	$20.9M	Sell	287,776 -20,173	-7%	-$1.36M	3.17%	3
2017 Q1	$20.1M	Sell	307,949 -46,021	-13%	-$2.89M	2.92%	9
2016 Q4	$22.2M	Sell	353,970 -655,538	-65%	-$40M	2.93%	9
2016 Q3	$63.7M	Sell	1,009,508 -355,692	-26%	-$23M	3.18%	4
2016 Q2	$84.5M	Sell	1,365,200 -730,352	-35%	-$44.5M	3.24%	8
2016 Q1	$120M	Sell	2,095,552 -308,310	-13%	-$17.2M	3%	8
2015 Q4	$142M	Buy	2,403,862 +669,687	+39%	+$38.6M	3.01%	10
2015 Q3	$94.4M	Buy	1,734,175 +710,638	+69%	+$46.3M	1.84%	30
2015 Q2	$68.8M	Buy	1,023,537 +967,881	+1,739%	+$63.2M	1.14%	37
2015 Q1	$3.25M	Sell	55,656 -2,992	-5%	-$181K	0.05%	64
2014 Q4	$3.84M	Buy	58,648 +13,756	+31%	+$867K	0.05%	68
2014 Q3	$2.59M	Buy	44,892 +16,001	+55%	+$888K	0.03%	79
2014 Q2	$1.63M	Buy	28,891 +477	+2%	+$25K	0.02%	110
2014 Q1	$1.46M	Sell	28,414 -70,051	-71%	-$3.54M	0.02%	102
2013 Q4	$5.2M	Buy	+98,465	New	+$4.84M	0.07%	63

Other funds holding ABBV

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Herndon Capital Management's ABBV Position: Q2 2017 in Review

Herndon Capital Management reduced its AbbVie (ABBV) stake by 6.6% in Q2 2017, selling an estimated $1.36M and leaving 287,776 shares worth $20.9M. The position accounts for 3.17% of the portfolio, ranked #3.

Herndon Capital Management first reported a position in ABBV in Q4 2013 and has held it in 15 quarters since. The position peaked at $142M in Q4 2015. 1,763 funds tracked by Wall St. Rank hold ABBV as of Q2 2017.

Herndon Capital Management held 287,776 shares of AbbVie worth $20.9M as of Q2 2017.
Herndon Capital Management sold 20,173 AbbVie shares in Q2 2017, an estimated $1.36M.
AbbVie made up 3.17% of Herndon Capital Management's portfolio in Q2 2017, its #3 holding.
Herndon Capital Management first reported a position in AbbVie in Q4 2013 and has held it in 15 quarters since.
Herndon Capital Management's AbbVie position peaked at $142M in Q4 2015.
1,763 funds tracked by Wall St. Rank held AbbVie as of Q2 2017.

Based on Herndon Capital Management's 13F filing for Q2 2017, filed 4 Aug 2017.